Previous studies have shown that E2F family members (mainly E2f1, E2f2, and E2f3) released after Rb1 inactivation could activate ARF, TAp73, and caspase and induce cancer cell apoptosis through p53-dependent or -independent pathways [26–28]. This evidence concerns the gene E2F2 and cancer.